
Insights Into NTRK Gene Fusion-Positive Thyroid Cancer
Perspectives on drivers in treatment pathways for NTRK fusion-positive cancers
Faculty Chair
Lori Wirth, MD
Massachusetts General Hospital Center for Head and Neck Cancers
More Information
- Virtual series
- Southern California, Nevada, Utah, Arizona, New Mexico, Colorado
REPORT SNAPSHOT
- A virtual, moderated roundtable discussion focusing on the treatment pathways for NTRK fusion-positive cancers
- Disease state and data presentations are developed in conjunction with a national or regional oncology expert
- Insights were obtained on the thyroid cancer disease landscape in the community setting, specifically testing protocols and treatment pathways for NTRK gene fusion-positive thyroid cancer
GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT
- Data collection is accomplished through use of audience response system questioning and moderated discussion
- The group of advisors will comprise 10–15 medical oncologists representative of each region